These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 3897972)
1. [In vitro antibacterial activity of cefodizime (HR 221) on 323 hospital strains of Gram negative bacilli. Comparison with cefotiam, cefoperazone, cefotetan and cefotaxime]. Le Noc P; Bryskier A; Le Noc D Pathol Biol (Paris); 1985 May; 33(5):399-403. PubMed ID: 3897972 [TBL] [Abstract][Full Text] [Related]
2. [In-vitro activity of ceftriaxone on Gram-negative bacilli with various resistance phenotypes to cephalosporins. Comparison with cefotaxime, cefmenoxime, moxalactam, ceftazidime]. Rouhan D; Le Noc P; Le Noc D Pathol Biol (Paris); 1986 May; 34(5):404-9. PubMed ID: 3534713 [TBL] [Abstract][Full Text] [Related]
3. [In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime]. Le Noc P; Bryskier A; Le Noc D Pathol Biol (Paris); 1983 May; 31(5):351-6. PubMed ID: 6312396 [TBL] [Abstract][Full Text] [Related]
4. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains]. Mascellino MT; Prignano G; Iegri F; Lorenzi A Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234 [TBL] [Abstract][Full Text] [Related]
5. [Comparison of antibacterial activities of cephalosporins]. Kayser FH; Kohler ML Schweiz Med Wochenschr; 1984 Feb; 114(5):156-61. PubMed ID: 6701496 [TBL] [Abstract][Full Text] [Related]
6. In vitro antimicrobial activity of cefodizime, a third generation cephalosporin. Pruksachatvuthi S; Aswapokee N; Aswapokee P J Med Assoc Thai; 1992 May; 75(5):287-92. PubMed ID: 1460409 [TBL] [Abstract][Full Text] [Related]
7. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics]. Miwatani T; Takeda Y; Kotera K; Nishimura T; Takashima T; Hiromatsu K; Tabuki K; Fujimoto S; Kamiki T; Yoshizaki E; Yabuuchi E; Shimizu Y; Matsunaga K; Yamanaka K; Furuta I; Iimori M; Kodama J; Tanaka M; Maejima K; Nukina M; Takashima E; Takahashi M; Harikane O; Masutani T Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368 [TBL] [Abstract][Full Text] [Related]
8. [Comparative antibacterial activity of a new monobactam, carumonam (RO 17-2301, AMA 1080) on hospital bacteria resistant to beta lactams]. Le Noc P; Croize J; Le Noc D Pathol Biol (Paris); 1987 May; 35(5):451-6. PubMed ID: 3302846 [TBL] [Abstract][Full Text] [Related]
9. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)]. Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385 [TBL] [Abstract][Full Text] [Related]
10. [In vitro antibacterial activity of eight third generation cephalosporins (author's transl)]. Deforges L; Le Van Thoi J; Soussy CJ; Duval J Pathol Biol (Paris); 1982 Jun; 30(6):363-9. PubMed ID: 6810282 [TBL] [Abstract][Full Text] [Related]
11. [In vitro activity of a new 3d-generation cephalosporin, cefodizime, on hospital bacteria]. Soussy CJ; Otterbein G; Le Van Thoi J; Duval J; Chanal M; Cluzel M; Sirot D Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):561-6. PubMed ID: 3534743 [TBL] [Abstract][Full Text] [Related]
13. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon]. Baumgärtner M; Grehn M; Wundt W Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):208-21. PubMed ID: 6289564 [TBL] [Abstract][Full Text] [Related]
14. [Comparative in vitro activity of 2 monobactams (RO 172301 (AMA 1080)and aztreonam), ceftazidime and cefotaxime on Gram-negative bacilli]. Thabaut A; Meyran M; Huerre M Pathol Biol (Paris); 1985 May; 33(5):404-7. PubMed ID: 3929217 [TBL] [Abstract][Full Text] [Related]
16. In vitro activity of ceftazidime and ceftriaxone. Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195 [TBL] [Abstract][Full Text] [Related]
17. The activity and beta-lactamase stability of cefotetan compared to other beta-lactam antibiotics. Neu HC; Chin NX Chemioterapia; 1985 Aug; 4(4):271-7. PubMed ID: 3876887 [TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro evaluation of BMY-28142, a new broad-spectrum cephalosporin, versus other beta-lactams against multiresistant gram-negative isolates. Giamarellou H; Sahin A; Chryssouli Z Drugs Exp Clin Res; 1987; 13(3):149-53. PubMed ID: 3622243 [TBL] [Abstract][Full Text] [Related]
19. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins]. Croize J; Le Noc P; Bryskier A; Robert J Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):564-8. PubMed ID: 3937128 [TBL] [Abstract][Full Text] [Related]
20. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli. Hall WH; Opfer BJ; Gerding DN Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]